A
Angela Criscimanna
Researcher at University of Palermo
Publications - 12
Citations - 1410
Angela Criscimanna is an academic researcher from University of Palermo. The author has contributed to research in topics: Metabolic syndrome & Type 1 diabetes. The author has an hindex of 11, co-authored 12 publications receiving 1103 citations.
Papers
More filters
Journal ArticleDOI
Visceral Adiposity Index: A reliable indicator of visceral fat function associated with cardiometabolic risk
Marco Calogero Amato,Carla Giordano,Massimo Galia,Angela Criscimanna,Salvatore Vitabile,Massimo Midiri,Aldo Galluzzo +6 more
TL;DR: This study suggests VAI is a valuable indicator of “visceral adipose function” and insulin sensitivity, and its increase is strongly associated with cardiometabolic risk.
Journal ArticleDOI
In vitro identification and characterization of CD133pos cancer stem-like cells in anaplastic thyroid carcinoma cell lines
Giovanni Zito,Pierina Richiusa,Alessandra Bommarito,Elvira Carissimi,Leonardo Russo,Antonina Coppola,Monica Zerilli,Vito Rodolico,Angela Criscimanna,Marco Calogero Amato,Giuseppe Pizzolanti,Aldo Galluzzo,Carla Giordano +12 more
TL;DR: ARO/CD133pos cells exhibit stem cell-like features - such as high proliferation, self-renewal ability, expression of OCT-4 - and are characterized by higher resistance to chemotherapy.
Journal ArticleDOI
Metabolic parameters and adipokine profile during GH replacement therapy in children with GH deficiency.
Alessandro Ciresi,Marco Calogero Amato,Angela Criscimanna,Antonina Mattina,Calogero Vetro,Aldo Galluzzo,Giuseppa D'Acquisto,Carla Giordano +7 more
TL;DR: GH replacement therapy in GHD children improved final height, restored IGF-I levels, reduced leptin levels, and improved the lipid profile, without producing any unfavorable effects on glucose metabolism.
Journal ArticleDOI
BRAFV600E mutation, TIMP-1 upregulation, and NF-κB activation: closing the loop on the papillary thyroid cancer trilogy.
Alessandra Bommarito,Pierina Richiusa,Elvira Carissimi,Giuseppe Pizzolanti,Vito Rodolico,Giovanni Zito,Angela Criscimanna,Francesco Di Blasi,Maria Pitrone,Monica Zerilli,Marco Calogero Amato,G. Spinelli,Valeria Carina,Giuseppe Modica,M Adelfio Latteri,Aldo Galluzzo,Carla Giordano +16 more
TL;DR: These findings demonstrate that BRAF(V600E) causes upregulation of TIMP-1 via NF-κB, which provides insight on how BRAF determines cancer initiation, progression, and invasiveness in PTC, also identifying new therapeutic targets for the treatment of highly aggressive forms.
Journal ArticleDOI
Multiple Pluripotent Stem Cell Markers in Human Anaplastic Thyroid Cancer: The Putative Upstream Role of SOX2
Valeria Carina,Giovanni Zito,Giuseppe Pizzolanti,Pierina Richiusa,Angela Criscimanna,Vito Rodolico,Laura Tomasello,Maria Pitrone,Walter Arancio,Carla Giordano +9 more
TL;DR: The data demonstrate that SOX2 switch-off through ABCG2 transporter down-regulation has a major role in overcoming CSC chemotherapy resistance and might be useful in identifying cells with a stem-like phenotype capable of resisting conventional chemotherapy.